Table 2.
Baseline characteristics for individuals with T2D and ASCVD, PAD, previous stroke or previous MI, and matched controls without ASCVD
| Characteristic | ASCVD (N = 80,305) | Matched controls (N = 80,305) | PAD (N = 15,397) | Matched controls (N = 15,397) | Previous stroke (N = 17,539) | Matched controls (N = 17,539) | Previous MI (N = 25,729) | Matched controls (N = 25,729) |
|---|---|---|---|---|---|---|---|---|
| Age, years, mean (SD) | 67.2 (8.4) | 67.0 (8.2) | 67.8 (8.9) | 67.5 (8.6) | 68.4 (8.3) | 68.1 (8.0) | 66.9 (8.4) | 66.7 (8.1) |
| Women, n (%) | 26,231 (32.7) | 25,834 (32.2) | 5206 (33.8) | 5118 (33.2) | 5990 (34.2) | 5854 (33.4) | 6792 (26.4) | 6680 (26.0) |
| Education, n (%) | ||||||||
| Compulsory | 31,510 (39.2) | 31,523 (39.3) | 6245 (40.6) | 6236 (40.5) | 7172 (40.9) | 7202 (41.1) | 10,234 (39.8) | 10,215 (39.7) |
| Upper secondary | 34,789 (43.3) | 34,825 (43.4) | 6710 (43.6) | 6727 (43.7) | 7406 (42.2) | 7398 (42.2) | 11,299 (43.9) | 11,311 (44.0) |
| University | 12,866 (16.0) | 12,886 (16.0) | 2260 (14.7) | 2265 (14.7) | 2664 (15.2) | 2652 (15.1) | 3896 (15.1) | 3922 (15.2) |
| Missing | 1140 (1.4) | 1071 (1.3) | 182 (1.2) | 169 (1.1) | 297 (1.7) | 287 (1.6) | 300 (1.2) | 281 (1.1) |
| Early retirement, n (%) | ||||||||
| At least part-timea | 38,283 (47.7) | 25,276 (31.5) | 8127 (52.8) | 4884 (31.7) | 9384 (53.5) | 5640 (32.2) | 11,389 (44.3) | 7863 (30.6) |
| Full-timea | 15,853 (19.7) | 9846 (12.3) | 3348 (21.7) | 1873 (12.2) | 4317 (24.6) | 2158 (12.3) | 4667 (18.1) | 3210 (12.5) |
| Comorbidities at baseline, n (%) | ||||||||
| Atrial fibrillation | 8650 (10.8) | 4562 (5.7) | 1645 (10.7) | 930 (6.0) | 2043 (11.6) | 1066 (6.1) | 2602 (10.1) | 1393 (5.4) |
| Heart failure | 8978 (11.2) | 1826 (2.3) | 2202 (14.3) | 364 (2.4) | 1586 (9.0) | 469 (2.7) | 3759 (14.6) | 602 (2.3) |
| Ischaemic heart disease | 51,809 (64.5) | 0 (0.0) | 5907 (38.4) | 0 (0.0) | 4453 (25.4) | 0 (0.0) | 25,729 (100.0) | 0 (0.0) |
| Myocardial infarction | 25,854 (32.2) | 0 (0.0) | 3170 (20.6) | 0 (0.0) | 2331 (13.3) | 0 (0.0) | 25,682 (99.8) | 0 (0.0) |
| Cerebrovascular disease | 18,716 (23.3) | 0 (0.0) | 2211 (14.4) | 0 (0.0) | 17,539 (100.0) | 0 (0.0) | 2465 (9.6) | 0 (0.0) |
| Peripheral artery disease | 12,967 (16.1) | 0 (0.0) | 12,967 (84.2) | 0 (0.0) | 1687 (9.6) | 0 (0.0) | 2581 (10.0) | 0 (0.0) |
| Amputation | 2301 (2.9) | 0 (0.0) | 2301 (14.9) | 0 (0.0) | 396 (2.3) | 0 (0.0) | 501 (1.9) | 0 (0.0) |
| Eye disease | 35,880 (44.7) | 28,423 (35.4) | 9380 (60.9) | 5668 (36.8) | 8759 (49.9) | 6497 (37.0) | 10,325 (40.1) | 8743 (34.0) |
| Neuropathy | 3854 (4.8) | 2821 (3.5) | 1007 (6.5) | 534 (3.5) | 694 (4.0) | 629 (3.6) | 1120 (4.4) | 852 (3.3) |
| Kidney disease | 16,869 (21.0) | 9254 (11.5) | 5868 (38.1) | 1825 (11.9) | 3556 (20.3) | 2118 (12.1) | 5023 (19.5) | 2924 (11.4) |
| End-stage renal disease | 1815 (2.3) | 640 (0.8) | 773 (5.0) | 124 (0.8) | 323 (1.8) | 136 (0.8) | 539 (2.1) | 201 (0.8) |
aFull-time early retirement was defined as 365 days per year, and part-time early retirement was defined as at least 180 days per year but less than 365 days
ASCVD atherosclerotic cardiovascular disease, MI myocardial infarction, PAD peripheral artery disease, SD standard deviation, T2D type 2 diabetes